| Elder Pharmaceuticals has reported a consolidated total income from operations of Rs 152.06 crore and a net loss of Rs 46.02 crore for the quarter ended Mar '15. | | For the quarter ended Mar 2014 the consolidated total income from operations was Rs 228.86 crore and net loss was Rs 73.63 crore. | | Elder Pharma shares closed at 91.55 on May 05, 2015 (NSE) |
|
| | Elder Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Mar '15 | Dec '14 | | | Mar '14 | | Net Sales/Income from operations | 151.30 | 156.90 | | | 227.41 | | Other Operating Income | 0.77 | 1.03 | | | 1.45 | | Total Income From Operations | 152.06 | 157.93 | | | 228.86 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 10.37 | 12.57 | | | 11.58 | | Purchase of Traded Goods | 85.46 | 84.54 | | | 124.01 | | Increase/Decrease in Stocks | -0.24 | 10.69 | | | -14.25 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 40.18 | 43.06 | | | 59.46 | | Depreciation | 10.42 | 8.93 | | | 9.53 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 27.90 | 37.60 | | | 56.59 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -22.01 | -39.45 | | | -18.07 | | Other Income | 1.05 | 0.94 | | | 12.73 | | P/L Before Int., Excpt. Items & Tax | -20.96 | -38.51 | | | -5.35 | | Interest | 22.46 | 45.05 | | | 69.46 | | P/L Before Exceptional Items & Tax | -43.42 | -83.56 | | | -74.81 | | Exceptional Items | 0.27 | -- | | | 2.90 | | P/L Before Tax | -43.14 | -83.56 | | | -71.91 | | Tax | 2.88 | -- | | | 1.72 | | P/L After Tax from Ordinary Activities | -46.02 | -83.56 | | | -73.63 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -46.02 | -83.56 | | | -73.63 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -- | -- | | | -- | | Net P/L After M.I & Associates | -46.02 | -83.56 | | | -73.63 | | Equity Share Capital | 20.54 | 20.54 | | | 20.54 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -22.41 | -40.69 | | | -35.85 | | Diluted EPS | -22.41 | -40.69 | | | -35.85 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -22.41 | -40.69 | | | -35.85 | | Diluted EPS | -22.41 | -40.69 | | | -35.85 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 1.54 | -- | | | 1.54 | | Share Holding (%) | 74.77 | -- | | | 75.17 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 0.44 | -- | | | 0.47 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 85.06 | -- | | | 91.49 | | - Per. of shares (as a % of the total Share Cap. of the company) | 21.46 | -- | | | 22.72 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 0.08 | -- | | | 0.04 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 14.94 | -- | | | 8.51 | | - Per. of shares (as a % of the total Share Cap. of the company) | 3.77 | -- | | | 2.11 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
